REFERENCES
- Felson DT, Anderson JJ, Boers M. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38:727–735.
- Firestein GS. Evolving concept of rheumatoid arthritis. Nature. 2003;423:356–361.
- Widdifield J, Paterson JM, Bernatsky S, et al. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheum. 2014;66:786–793.
- Turesson C, O’Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62:722–727.
- Harper SL, Foster CS. The ocular manifestation of rheumatoid disease. Int Ophthalmol Clin. 1998;38:1–19.
- Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984;91:1253–1263.
- Artifoni M, Rothschild PR, Brezin A, et al. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat. Rev. Rheumatol. 2014;10:108–116.
- Moreland LW, Curtis JR. Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms. Semin Arthritis Rheum. 2009;39:132–43.
- Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.
- Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117:1792–1799.
- Chung SE, Kang SW, Lee JH, et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011;118:840–845.
- Koizumi H, Yamagishi T, Yamazaki T, et al. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:1123–1128.
- Aletaha D, Neogi T, Silman A, et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative initiative. Arthritis Rheum. 2010;62:2569–2581.
- Prevoo MLL, Van’t Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty‐eight‐joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–48.
- Van Gestel AM, Haagsma CJ, Van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998;41:1845–1850.
- Brühlmann P, Stucki G, Michel BA. Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis. J Rheumatol. 1994;21:1245–1249.
- Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010;29:144–168.
- Coşkun E, Gurler B, Pehlivan Y, et al. Enhanced depth imaging optical coherence tomography findings in Behçet disease. Ocular Immunol Inflamm. 2013;21:440–445.
- Kola M, Kalkisim A, Karkucak M, et al. Evaluation of choroidal thickness in anklylosing spondylitis using optical coherence tomography. Ocul Immunol Inflamm. 2014;22:434–438.
- Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiography changes. Invest Ophthalmol Vis Sci. 2013;54:6033–6039.
- Prete M, Racanelli V, Digiglio L, et al. Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev. 2011;11:123–131.
- Zlatanovic G, Veselinovic D, Cekic S, et al. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci. 2010;10:323–327.
- Akpek E.K, Thorne J.E, Qazi F.A, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501–506.
- De Machado O, Curi AL, Bessa TF, et al. Posterior scleritis: clinical features, systemic association, treatment and evolution of 23 patients. Arq Bras Oftalmol. 2009;72:321–326.
- Uchihori H, Nakai K, Ikuno Y, et al. Choroidal observation in posterior scleritis using high-penetration optical coherence tomography. Int Ophthalmol. 2014;34:937–943.
- Duru N, Altinkaynak H, Ertan Ş, et al. Thinning of choroidal thickness in patients with rheumatoid arthritis unrelated to disease activity. Ocul Immunol Inflamm. 2015;31:1–8.
- Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006;36:88–98.
- Vollertsen RS, Conn DL. Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am. 1990;16:445–461.
- Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9:71–92.
- Giordano N, D’Ettorre M, Biasi G, et al. Retinal vasculitis in rheumatoid arthritis: an angiographic study. Clin Exp Rheumatol. 1990;8:121–125.
- Matsuo T, Masuda I, Matsua N. Geographic choroiditis and retinal vasculitis in rheumatoid arthritis. Jpn J Ophthalmol. 1998;42:51–55.
- Wu CC, Yu HC, Yen JH, et al. Rare extra-articular manifestation of rheumatoid arthritis: scleromalacia perforans. Kaohsiung J Med Sci. 2005;21:233–235.
- Itty S, Pulido JS, Bakri SJ, et al. Anti-cyclic citrullinate peptide, rheumatoid factor and ocular symptoms typical of rheumatoid arthritis. Trans Am Ophthalmol Soc. 2008;106:75–81.